Comparative evaluation of Panther Fusion and real-time PCR for detection of Burkholderia pseudomallei in spiked human blood
暂无分享,去创建一个
P. Harris | M. Bauer | R. Norton | I. Gassiep | Melissa Page
[1] M. Chatfield,et al. The epidemiology of melioidosis in Townsville, Australia. , 2021, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[2] R. Price,et al. The Darwin Prospective Melioidosis Study: a 30-year prospective, observational investigation. , 2021, The Lancet. Infectious diseases.
[3] D. Limmathurotsakul,et al. A multi-country study using MALDI-TOF mass spectrometry for rapid identification of Burkholderia pseudomallei , 2021, BMC microbiology.
[4] P. Harris,et al. Diagnosis of melioidosis: the role of molecular techniques. , 2021, Future microbiology.
[5] S. Ombelet,et al. Nonautomated Blood Cultures in a Low-Resource Setting: Optimizing the Timing of Blind Subculture , 2020, The American journal of tropical medicine and hygiene.
[6] K. Stellrecht,et al. The Panther Fusion System with Open Access Functionality for Laboratory-Developed Tests for Influenza A Virus Subtyping , 2020, Journal of Clinical Microbiology.
[7] R. Norton,et al. Human Melioidosis , 2020, Clinical Microbiology Reviews.
[8] N. Day,et al. Clinical Epidemiology of 7126 Melioidosis Patients in Thailand and the Implications for a National Notifiable Diseases Surveillance System , 2019, Open forum infectious diseases.
[9] E. Bertherat,et al. Global burden of melioidosis in 2015: a systematic review and data synthesis. , 2019, The Lancet. Infectious diseases.
[10] R. Norton,et al. Identification of Burkholderia pseudomallei by Use of the Vitek Mass Spectrometer , 2019, Journal of Clinical Microbiology.
[11] Hyunwoong Park,et al. Comparison of Clinical Performance Between BacT/Alert Virtuo and BacT/Alert 3D Blood Culture Systems , 2019, Annals of laboratory medicine.
[12] Sarah K. Parker,et al. Implementation of Rapid Molecular Infectious Disease Diagnostics: the Role of Diagnostic and Antimicrobial Stewardship , 2016, Journal of Clinical Microbiology.
[13] S. Hay,et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis , 2016, Nature Microbiology.
[14] A. Hoffmaster,et al. Comparison of DNA Extraction Kits for Detection of Burkholderia pseudomallei in Spiked Human Whole Blood Using Real-Time PCR , 2013, PloS one.
[15] Talima Pearson,et al. Comparison of TaqMan PCR Assays for Detection of the Melioidosis Agent Burkholderia pseudomallei in Clinical Specimens , 2012, Journal of Clinical Microbiology.
[16] Claudio J. Verzilli,et al. Defining the True Sensitivity of Culture for the Diagnosis of Melioidosis Using Bayesian Latent Class Models , 2010, PloS one.
[17] Eileen M. Burd,et al. Validation of Laboratory-Developed Molecular Assays for Infectious Diseases , 2010, Clinical Microbiology Reviews.
[18] N. Day,et al. Loop-Mediated Isothermal Amplification Method Targeting the TTS1 Gene Cluster for Detection of Burkholderia pseudomallei and Diagnosis of Melioidosis , 2007, Journal of Clinical Microbiology.
[19] N. Day,et al. Quantitation of B. Pseudomallei in clinical samples. , 2007, The American journal of tropical medicine and hygiene.
[20] Ryan T Novak,et al. Clinical Evaluation of a Type III Secretion System Real-Time PCR Assay for Diagnosing Melioidosis , 2006, Journal of Clinical Microbiology.
[21] Ryan T Novak,et al. Development and Evaluation of a Real-Time PCR Assay Targeting the Type III Secretion System of Burkholderia pseudomallei , 2006, Journal of Clinical Microbiology.
[22] C. Hart,et al. Evidence for the presence in Burkholderia pseudomallei of a type III secretion system-associated gene cluster. , 1999, Journal of medical microbiology.
[23] T. Dharakul,et al. Speed of detection of Burkholderia pseudomallei in blood cultures and its correlation with the clinical outcome. , 1997, The American journal of tropical medicine and hygiene.
[24] A. E. Lew,et al. Detection of Pseudomonas pseudomallei by PCR and hybridization , 1994, Journal of clinical microbiology.